Arcturus Therapeutics Holdings Inc (ARCT) financials
Arcturus Therapeutics revenue and earnings by year
Arcturus Therapeutics's revenue was $82.0 million in the fiscal year to December 31, 2025, down 46.1% from the year before. Net income was -$65.8 million, -80.2% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 16.7% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 82 | 152 | 167 | 206 | 12 | 10 | 21 | 16 | 13 | 20 |
| Revenue growth | -46.1% | -8.7% | -19.0% | 1566.8% | 29.6% | -54.1% | 32.0% | 21.2% | -36.2% | — |
| Operating income | -76 | -96 | -78 | 12 | -203 | -72 | -26 | -22 | -10 | -1 |
| Operating margin | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% | -749.8% | -122.7% | -138.5% | -80.7% | -4.9% |
| Net income | -66 | -81 | -30 | 9 | -204 | -72 | -26 | -22 | -11 | -2 |
| Net margin | -80.2% | -53.1% | -17.8% | 4.5% | -1648.0% | -756.3% | -125.0% | -138.3% | -83.9% | -7.7% |
| Diluted EPS | -$2.40 | -$3.00 | -$1.12 | $0.35 | -$7.74 | -$3.50 | -$2.13 | -$2.16 | — | — |
| Free cash flow | -75 | -60 | -21 | 24 | -138 | -45 | -7 | -22 | -1 | -4 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ARCT in Markets.
How Arcturus Therapeutics makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Grant | $2.08M | 70.3% |
| Collaboration Revenue | $880K | 29.7% |
See also: ARCT returns
No forecast, no recommendation. This page describes Arcturus Therapeutics Holdings Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.